According to Basilea Pharmaceutica's latest financial reports the company's total assets are โฌ0.19 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | โฌ0.18 B | -16.34% |
2022-12-31 | โฌ0.22 B | -6.73% |
2021-12-31 | โฌ0.23 B | 12.76% |
2020-12-31 | โฌ0.21 B | 3.83% |
2019-12-31 | โฌ0.20 B | -18.49% |
2018-12-31 | โฌ0.25 B | -16.69% |
2017-12-31 | โฌ0.30 B | -1.74% |
2016-12-31 | โฌ0.30 B | -17.13% |
2015-12-31 | โฌ0.36 B | 72.42% |
2014-12-31 | โฌ0.21 B | -12.5% |
2013-12-31 | โฌ0.24 B | -21.32% |
2012-12-31 | โฌ0.31 B | 59.77% |
2011-12-31 | โฌ0.19 B | -23.58% |
2010-12-31 | โฌ0.25 B | 82.63% |
2009-12-31 | โฌ0.13 B | -38.04% |
2008-12-31 | โฌ0.22 B | -19.39% |
2007-12-31 | โฌ0.27 B | 120.68% |
2006-12-31 | โฌ0.12 B | -22.84% |
2005-12-31 | โฌ0.16 B | 9.91% |
2004-12-31 | โฌ0.14 B | 117.01% |
2003-12-31 | โฌ68.73 M | -56.49% |
2002-12-31 | โฌ0.15 B |